CNBCLean R·
AstraZeneca may buck a decade of pharma strategy to buy U.S. scale
Reports of preliminary talks between AstraZeneca and Bristol Myers Squibb moved shares and reignited debate over Big Pharma consolidation.
Read at CNBC →
Reports of preliminary talks between AstraZeneca and Bristol Myers Squibb moved shares and reignited debate over Big Pharma consolidation.
<iframe src="https://statesidedaily.com/embed/cluster/088c7ee14d03f63bfcd3ba6c1f72319633d10841" width="100%" height="320" style="border:0;max-width:680px" loading="lazy" title="AstraZeneca may buck a decade of pharma strategy to buy U.S. scale"></iframe>